MedPath

Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence

Not Applicable
Recruiting
Conditions
Acupressure, Intensive Care Unit, Anxiety, Nursing Presence, Sleep Quality, Physiological Parameters
Registration Number
NCT06994715
Lead Sponsor
Gazi University
Brief Summary

This study will be conducted in a randomized controlled experimental design to examine the effects of acupressure applied to patients treated in the intensive care unit on physiological parameters, pain, sleep quality, anxiety and perception of nurse presence. The study will be conducted with 60 patients (20 intervention, 20 placebo, 20 control groups) treated in the 2nd stage Intensive Care Unit of an University Hospital between May 2025 and January 2026. Acupressure will be applied to the intervention group for 2 days, morning and evening, for four sessions. For four sessions, pseudo acupressure will be used on the placebo group for 2 days, morning and evening. No application will be made to the control group. The data collection tools in the study are the Patient Identifier Information Form, Glasgow Coma Scale (GCS), Visual Assessment Scale (VAS), Physiological Parameter Assessment Form, Richards-Campbell Sleep Scale, Spielberg State-Trait Anxiety Inventory, and Nurse Presence Scale (PONS).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Have received intensive care treatment for at least 48 hours,
  • Are 18 years of age or older,
  • Have a Glasgow Coma Scale score of >13,
  • Can speak and write in Turkish,
  • Have no psychiatric diagnosis,
  • Have no communication problems,
  • Have a VAS score of ≥1,
  • Have a mean arterial pressure of ≥65,
  • Have SpO2 of ≥85.
Exclusion Criteria

Have previously received acupressure treatment,

  • Have ulcers, necrotic tissue and signs and symptoms of infection at the points where pressure will be applied,
  • Have used antihypertensives, beta-blockers and similar medications,
  • Have sedation,
  • Have respiratory support from the device,
  • Have inotropic treatment (dopamine, steradin and others),
  • Have analgesic treatment in their routine treatment will not be included in the study.

Patients who were discharged during the study,

  • Patients who died during the study,
  • Patients who wanted to leave the study,
  • Patients who started receiving sedation during the application,
  • Patients who added antihypertensive, beta-blocker and similar drugs to their routine treatment during the application,
  • Patients who received inotropic treatment (dopamine, steradin and others) during the application,
  • Patients who started receiving analgesia treatment during the application,
  • Patients who developed ulcers, necrotic tissue and infection at the points where pressure will be applied during the application,
  • Patients who started receiving respiratory support from the device during the application,
  • Patients who had a Glasgow Coma Scale score of ≤13, mean arterial pressure of ≤65 and SpO2 of ≤85 during the application will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual Assessment Scale1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application

VAS is a measurement tool frequently used in the clinic for pain assessment. The ruler, which is indicated as 0-10 cm or 0-100 mm, has no pain (0) written on one end and the most severe pain (10) on the other end. It is scored between 0-10. The patient marks the point on the ruler where he feels the pain.

Spielberg State-Trait Anxiety Scale1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application and third day morning.

The scale consists of two sub-dimensions measuring continuous and state anxiety. There are 20 questions for each sub-dimension on a 4-point Likert scale (not at all = 1, a little = 2, a lot = 3, completely = 4). The minimum-maximum score range that can be obtained from the scale varies between 20-80. Increasing scores on the scale indicate an increase in the level of anxiety.

Physiological Parameters Assessment Form1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application

Systolic Blood Pressure (mm/Hg), Diastolic Blood Pressure (mm/Hg), Respiratory Rate, Heart Rate (Pulse) (beats/min) and Saturation parameters measured before and after acupressure of the intervention and placebo groups will be recorded. Systolic blood pressure measurements will be averaged. Diastolic blood pressure measurements will be averaged. Saturation measurements will be averaged. Respiratory rate measurements will be averaged. Heart Rate (Pulse) measurements will be averaged.

Nursing Presence Scale1st day 15 minutes before application and third day morning.

The scale designed as a 5-point Likert is scored as follows; (never: 1 point), (rarely: 2 points), (occasionally/sometimes: 3 points), (frequently: 4 points) and (always: 5 points). The minimum and maximum scores that can be obtained from the scale are calculated between 24-120. An increase in the score obtained from the scale means that the behaviors in which the patient presents the presence of the nurse have increased and that the patient perceives these behaviors positively.

Secondary Outcome Measures
NameTimeMethod
Richards-Campbell Sleep Scale1st day and second day- morning and evening; 15 minutes before application and 30 minutes after the application and third day morning.

The scale consists of 6 items in total. Each item on the scale is graded between 0 and 100 points. The result is found by dividing the total score obtained from the scale by the number of questions. A score between "0-25" indicates very poor sleep, and a score between "76-100" indicates very good sleep. The minimum score on the scale is calculated as 0, and the maximum score is calculated as 100. An increase in the score obtained from the scale indicates an increase in sleep quality.

Trial Locations

Locations (1)

Ozlem Canbolat

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath